Recon: UK picks Pfizer to supply RSV vaccine jabs; Alnylam touts positive Phase 3 results for heart drug

• Project Optimus: Sponsors Register Concerns, Questions (Pink Sheet)
• Lykos’ pain is others’ gain as psychedelic biotechs take notes from adcomm vote (Endpoints)
• Déjà Vu: CBER Director’s Intervention Saves Sarepta’s Elevidys Again (Pink Sheet)
• News We’re Watching: Boston Sci Buys Silk Road Medical; EOFlow Injunction Blocked; LDT Compliance Dates Announced (MedTech Insight)
• Appeals court does not block US mandate to cover cancer screenings, HIV drugs (Reuters)

• Steward Health Care executives are mired in trouble at home. In Malta, it’s much worse (STAT)
• UK taps Pfizer over hometown GSK to supply RSV vaccine doses (Endpoints)
• EU RWE Projects Show The ‘Data Revolution In Health Research' Is Here (Pink Sheet)
• Council Of EU Aligned With Parliament Over Need For Future MDR Amendments (MedTech Insight)
• UK NHS, Industry Agreement On Artificial Pancreas Pricing Clears Way For Takeoff (MedTech Insight)

• Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval (STAT)
• Commercial-stage blood cancer biotech files for US dual listing (Endpoints)
• Schizophrenia biotech LB Pharmaceuticals eyes near-term IPO filing — source (Endpoints)
• Amylyx, searching for post-ALS future, licenses a GLP-1 drug (Endpoints)
• Alumis aims for this year’s third-largest biotech IPO as it readies for Phase 3 (Endpoints)
• ‘Is This Doomsday Concern, Or Is It Reality?’ Verily CMO On AI’s Future, Lightpath Metabolic, More (MedTech Insight)
• A biotech’s binary bet ends badly (STAT)

• Orthofix’s president of global orthopedics resigns (MedTech Dive)
• Tandem names Jean-Claude Kyrillos as chief operating officer (MedTech Dive)
• Philips Respironics to end manufacturing at two Pennsylvania plants: report (MedTech Dive)
• J&J creates open digital platform for surgical applications (MedTech Dive)
• ONC’s Micky Tripathi on laying the digital floor for healthcare AI (MedTech Dive)
• Former Stimwave CEO gets 6 years in prison for fake device scheme (MedTech Dive)
• Q&A: How Kaiser Permanente tracks and weeds out risky medical devices (STAT)

• The FDA needs to embrace phage therapy to help fight antimicrobial resistance (STAT)
• Ateev Mehrotra, the researcher the telehealth lobby loves to hate, isn’t backing down (STAT)
• Bird flu snapshot: USDA secretary urges farmers to take protective measures (STAT)
• Two years since Dobbs, reproductive freedom must be protected from assault (STAT)
• FDA Finalizes Definitions Of Delaying Or Denying Inspections (MedTech Insight)
• Doctor's recommendation does not bar patient's lawsuit over device -California top court (Reuters)